An official website of the United States government
This repository is under review for potential modification in compliance with Administration directives.
Publication Information
Affiliation
Division of Endocrinology, University of Miami, Miami, Florida, USA. jsosenko@med.miami.edu
Authors
Cowie CC, Cuthbertson D, Diabetes Prevention Trial-Type 1 Study Group, Greenbaum CJ, Krischer JP, Mahon J, Palmer JP, Rafkin-Mervis L, Skyler JS, Sosenko JM
Studies
Citation
Sosenko JM, Palmer JP, Rafkin-Mervis L, Krischer JP, Cuthbertson D, Mahon J, Greenbaum CJ, Cowie CC, Skyler JS, Diabetes Prevention Trial-Type 1 Study Group. Incident dysglycemia and progression to type 1 diabetes among participants in the Diabetes Prevention Trial-Type 1. Diabetes Care 2009 Sep;32(9):1603-7. Epub 2009 Jun 1.Abstract
We studied the incidence of dysglycemia and its prediction of the development of type 1 diabetes in islet cell autoantibody (ICA)-positive individuals. In addition, we assessed whether dysglycemia was sustained.